18-13029811-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032142.4(CEP192):āc.1199A>Gā(p.Asn400Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000902 in 1,551,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032142.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP192 | NM_032142.4 | c.1199A>G | p.Asn400Ser | missense_variant | 10/45 | ENST00000506447.5 | NP_115518.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP192 | ENST00000506447.5 | c.1199A>G | p.Asn400Ser | missense_variant | 10/45 | 5 | NM_032142.4 | ENSP00000427550 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000649 AC: 1AN: 154026Hom.: 0 AF XY: 0.0000122 AC XY: 1AN XY: 81728
GnomAD4 exome AF: 0.00000929 AC: 13AN: 1399370Hom.: 0 Cov.: 31 AF XY: 0.00000869 AC XY: 6AN XY: 690190
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.1199A>G (p.N400S) alteration is located in exon 10 (coding exon 9) of the CEP192 gene. This alteration results from a A to G substitution at nucleotide position 1199, causing the asparagine (N) at amino acid position 400 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at